Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

Dimitrios Balafoutas, Axel zur Hausen, Sebastian Mayer, Marc Hirschfeld, Markus Jaeger, Dominik Denschlag, Gerald Gitsch, Achim Jungbluth, Elmar Stickeler

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)
Original languageEnglish
Article number271
JournalBMC Cancer
Volume13
DOIs
Publication statusPublished - 3 Jun 2013

Keywords

  • Breast Cancer
  • Cancer-testis Antigen
  • NY-BR-1
  • Immunotherapy
  • Prognosis

Cite this

Balafoutas, D., zur Hausen, A., Mayer, S., Hirschfeld, M., Jaeger, M., Denschlag, D., Gitsch, G., Jungbluth, A., & Stickeler, E. (2013). Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications. BMC Cancer, 13, [271]. https://doi.org/10.1186/1471-2407-13-271